Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Joel Montane
 -- 2626 2022-12-22 12:23:53 |
2 format
Jason Zhu
 Meta information modification 2626 2022-12-23 04:47:36 |

Video Upload Options

Do you have a full video?
Send video materials Upload full video

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Magaña, J.C.;  Deus, C.M.;  Giné-Garriga, M.;  Montané, J.;  Pereira, S.P. Exercise-Boosted Mitochondrial Remodeling in Parkinson’s Disease. Encyclopedia. Available online: https://encyclopedia.pub/entry/39090 (accessed on 02 July 2024).
Magaña JC,  Deus CM,  Giné-Garriga M,  Montané J,  Pereira SP. Exercise-Boosted Mitochondrial Remodeling in Parkinson’s Disease. Encyclopedia. Available at: https://encyclopedia.pub/entry/39090. Accessed July 02, 2024.
Magaña, Juan Carlos, Cláudia M. Deus, Maria Giné-Garriga, Joel Montané, Susana P. Pereira. "Exercise-Boosted Mitochondrial Remodeling in Parkinson’s Disease" Encyclopedia, https://encyclopedia.pub/entry/39090 (accessed July 02, 2024).
Magaña, J.C.,  Deus, C.M.,  Giné-Garriga, M.,  Montané, J., & Pereira, S.P. (2022, December 22). Exercise-Boosted Mitochondrial Remodeling in Parkinson’s Disease. In Encyclopedia. https://encyclopedia.pub/entry/39090
Magaña, Juan Carlos, et al. "Exercise-Boosted Mitochondrial Remodeling in Parkinson’s Disease." Encyclopedia. Web. 22 December, 2022.
Exercise-Boosted Mitochondrial Remodeling in Parkinson’s Disease
Edit
This entry is adapted from the peer-reviewed paper 10.3390/biomedicines10123228

Parkinson’s disease (PD) is a movement disorder characterized by the progressive degeneration of dopaminergic neurons resulting in dopamine deficiency in the striatum. Given the estimated escalation in the number of people with PD, interventions aimed at minimizing morbidity and improving quality of life are crucial. Mitochondrial dysfunction and oxidative stress are intrinsic factors related to PD pathogenesis. Accumulating evidence suggests that patients with PD might benefit from various forms of exercise in diverse ways, from general health improvements to disease-specific effects and, potentially, disease-modifying effects.

Parkinson’s disease mitochondrial remodeling exercise

1. Introduction

Neurodegenerative disorders encompass a wide range of conditions resulting from a progressive process of degeneration of the function and structure of the central and/or peripheral nervous system [1]. Common neurodegenerative disorders include Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). Among them, PD is the second most prevalent neurodegenerative disorder after AD, and the most common disorder that affects motor coordination [1]. In adults, the prevalence of PD ranges from 1 to 2 per 1000 [2]. While PD is rare before 50 years old, PD affects 2% of the population above 65 years old and 4% of the population above 80 years old [3]. Worldwide, people are living longer and the population aging is faster than in the past, so the prevalence of PD is expected to increase at an accelerated pace in the coming years. By 2040, the number of people with PD worldwide is projected to exceed 12 million [4]. Dorsey et. al. labels PD a growing Pandemic fueled by an aging population, increased longevity, and the byproducts of industrialization [5]. The annual incidence in high-income countries is 14 per 100,000 people in the total population and 160 per 100,000 people over 65 years old [3]. However, there could be several discrepancies regarding PD incidence data, probably due to methodological differences, particularly differences in case ascertainment and diagnostic criteria used [2]. A measurement of the frequency of PD is lifetime risk, which was estimated to be 2% for 40-year-old men and 1–3% for women in the United States (US) population and taking into account competing risks, such as death from other causes, including cardiovascular diseases or cancer [6]. Although the sporadic form of PD (unknown cause) is the most prevalent, around 10–15% of PD patients exhibit the familial form, resulting from a mutation in one or several specific genes [7]. Currently, at least ten mutated genes have been linked with familial PD, including α-synuclein (PARK1), Parkin (PARK2), ubiquitin C-terminal hydrolase L1 (UCH-L1 or PARK5), PTEN-induced kinase 1 (PINK1 or PARK6), DJ-1 (PARK7), leucine-rich repeat kinase 2 (LRRK2 or PARK8), ATPase 13A2 (ATP13A2 or PARK9), phospholipase A2 group VI (PLA2G6 or PARK14), F-Box protein 7 (FBXO7 or PARK15), and GRB10 interacting GYF protein 2 (GIGYF or PARK11) [8][9].

2. Types of Exercise Applied to Parkinson’s Disease Patients

The characteristic motor and nonmotor impairments in PD patients might motivate the individuals to adopt a sedentary lifestyle, reflecting a deliberate compensatory strategy to prevent further complications, observed, for example, in patients with severe postural instability who try to avoid falls by staying indoors. Indeed, fear of falling is common in patients with PD, and might cause a reduction in their outdoor physical activities [10]. Nevertheless, this precautionary physical inactivity can have deleterious assets in several clinical domains of PD. Accumulating evidence suggests that patients with PD might benefit from PA and exercise in a number of ways, from general improvements in health to disease-specific effects, finally improving their quality of life [11]. For this reason, the ACSM has recently published several guidelines to implement exercise in PD patients in order to create a competency framework for professionals to ensure that people with PD are receiving appropriate, safe, and effective instruction and programs [12].
The different types of exercise programs that bring forward an integral impact on the physical and mental wellbeing of patients with PD include muscular relaxation and activation exercises [13], treadmill gait training [14][15][16][17], body-weight-supported treadmill training [18][19][20], and robot-assisted gait training [21][22]; virtual reality [23][24][25]; aerobic exercise training mainly stationary bicycle [26][27][28][29][30][31][32][33]; balance training [34][35]; exercise + games = exergames [36][37]; high-intensity eccentric resistance training [38]; progressive resistance training [39]; and qigong, tai chi, tango, and yoga [40][41]. The impact of most of these interventions also translates into improved quality of life [18][21][29][35][38][40][42][43][44].
Scientific evidence increasingly reinforces exercise-based interventions as a benchmark for slowing down the neurodegenerative processes associated with PD [42][43][45]. Modest tendencies towards the decrease in oxidative stress and the increase in antioxidant capacity in PD patients have been shown after a resistance training program [44]. Two biomarkers of oxidative stress (malondialdehyde (MDA) and hydrogen peroxide (H2O2)) were reduced after exercise training (15% and 16%, respectively), highlighting the capacity of the structured physical exercise to improve the oxidative state in people with PD [44].
Batouli and Saba concluded that a large network of brain areas, equivalent to 82% of the total volume of gray matter, was modifiable by PA [46]. The hippocampus was the brain region most affected by exercise [46]. Furthermore, exercise influences neurogenesis in the hippocampal dentate gyrus [47]. According to the prion hypothesis, α-synuclein spreads through neuronal connections and glia [48]. This propagation in the fourth stage of neuropathological course related to PD [49] reaches the hippocampus [50], producing changes in the proteins associated with synaptic structures and altering neuronal communication and function [51]. Owing to compensation and plasticity effects, during the progression of PD, training in daily living activities has been shown to restore neural circuits for movement, allowing intact nervous systems [52]. Where they can be key, there exist the cortico-ponto-cerebellar-thalamic-cortical circuits and/or cerebellum-thalamus-ganglia circuits [52], especially in the prodromal period in which non-motor manifestations are described [51][53], because, in stage III, motor symptoms appear as a result of damage in the SNpc [49][51].
Some limitations exist to specifying which symptoms respond to exercise, namely the fact that a large number of clinical trials have exclusion criteria in their design that do not allow further study of some of the symptoms and associated comorbidities. In this sense, subjects with orthostatic hypotension, dementia, and comorbidities such as stroke and degenerative osteoarthritis are normally excluded [44]. According to the ACSM, apathy, depression, and fatigue are some of the non-motor symptoms in PD, which can hinder the patient’s ability to participate in physical exercise interventions. Although the benefits of engaging in PA are known, these and other non-motor symptoms are often overlooked and underdetermined when a patient is encouraged to exercise.

3. Muscle–Brain Crosstalk in Parkinson’s Disease: The Role of Exercise Secretome

For a long time, PD was perceived as a brain disease with neurodegenerative deterioration [54][55]; today, PD is seen as a multiorgan and multisystemic pathology [54][55][56]. Therefore, exercise becomes a strong ally, where accumulating evidence shows that the role of muscular secretory activity, such as adaptation to regular exercise, is crucial [57]. Thus, exercise is responsible for both systemic [58] and neural plasticity [59]. This is achieved and developed by the plasticity of the skeletal muscle that has repercussions at the cellular and molecular level [60][61].
The skeletal muscle is an endocrine organ capable of secreting a variety of neurotrophic factors with neuroprotective and beneficial effects [62]. For example, neurological disorders, impaired cognition, dementia, and depression are associated with lower levels of circulating brain-derived neurotrophic factor (BDNF), which can be mitigated by exercise [63]. BDNF release during muscle contraction reaches the brain and binds to tropomyosin receptor kinase B (TrkB), inducing the phosphorylation of several signaling pathways, including phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target rapamycin (mTOR), PI3K/AKT/mTOR pathway, PI3K/extracellular signal-regulated kinase (ERK)/cAMP responsive element-binding protein (CREB), and Pi3k/ERK/CREB pathway [64][65]. The activation of these signaling pathways leads to the secretion of additional BDNF. Moreover, BDNF promotes the activation of nuclear factor erythroid 2-related factor 2 (Nrf2), which is the master regulator of antioxidant defense systems protecting brain cells from oxidants, inflammatory agents, and electrophiles. Nrf2 system was also implicated in mitochondrial biogenesis and mitochondrial quality control as well with protein homeostasis and cellular redox [64][65].
Exercise-induced cathepsin B release from skeletal muscle elevates BDNF abundance in the hippocampus, which has been linked to neuroprotection and improved memory function [66]. Many of these molecular adaptations are mediated by PGC-1α [58].
PGC-1α coordinates the transcription of several biological programs, including mitochondrial function, oxidative metabolism, and Ca2+ homeostasis [67], and is also involved in the control of various myokines [68]. PGC-1α increase also leads to the biosynthesis of kynurenine aminotransferases, thus preventing its toxic accumulation in the brain [69]. In addition, it has been shown that exercise enhances neuronal gene expression of fibronectin type III domain-containing protein 5 (FNDC5), whose protein product could stimulate brain-derived neurotrophic factor in the hippocampus [70]. The endocrine property of muscle cells also includes the release of cytokines (e.g., IL-6) or metabolites (e.g., lactate) [69].
Actually, muscle–brain crosstalk is mediated by myokines and metabolites released by muscle, but the brain also senses exercise indirectly through secretion of adipokines and hepatokines, which can cross the blood–brain barrier [71]. Exercise induces the secretion of the hormone adiponectin derived from adipose tissue, which improves hippocampal neurogenesis and has relevant antidepressant effects [69][72]. In addition, exercise promotes molecules derived from muscle and liver to enter the brain and send signals to receptors located on endothelial, glial, or neuronal cells, thereby triggering the expression of vascular endothelial growth factor (VEGF) and BDNF, key regulators of brain vascularization and plasticity [69], mediating the effects of exercise on the brain. Thus, the identification of exercise-related factors that have a direct or indirect effect on brain function has the potential to highlight new therapeutic targets for neurodegenerative diseases and cognitive enhancers for people of all ages [73].
Information about the specific molecular mechanisms occurring in PD patients’ brains and its modulation by PA is limited, as the study of the human nervous system encounters great difficulty because of its inaccessibility in living patients. Suitable healthy and “only PD” human tissues, uncomplicated by confounding pathologies, are very rarely, if ever, available to investigate. Human brain samples are obtained at autopsy in pathological situations after a variable period without functioning circulation that can markedly influence the amount and state of biomolecules [74]. In addition, cell and animal models do not fully reproduce the pathologies or phenotypes associated with old age [75]. For this reason, the use of peripherally accessible tissues, such as skin cells, has gained interest, making it possible to evaluate mitochondrial bioenergetic defects, to correlate the severity of the symptoms, and to search for biomarkers of the pathogenesis in PD [76][77][78][79].

4. Exercised Mitochondria, a Cross-Optimization of Metabolic Pathways with Potential to Slow down PD Progression?

Physical activity and exercise affect mitochondrial dynamics and function in all organs in a number of ways that may vary depending on exercise intensity. Acute exercise activates a number of pathways related to PGC-1α, which controls mitochondrial biogenesis through Ca2+/calmodulin-dependent protein (CaMK), p38 mitogen-activated protein kinase (MAPK), AMP-activated protein kinase (AMPK), and tumor suppressor protein 53 (p53) signaling. For instance, an increase in cytosolic Ca2+ induces PGC-1α, Nrf1, Nrf2, and mitochondrial transcription factor A (TFAM) in L6 myotubes [80]. Further, by increasing PGC-1α promoter activity, the p38-MAPK pathway is also able to induce mitochondrial biogenesis [81]. Additionally, it has been demonstrated that electrical stimulation and exercise result in an increase in AMPK activity [82][83].
The tumor suppressor p53 is also involved in the regulation of mitochondrial biogenesis in cardiomyocytes [78]. Several studies demonstrate that p53 deletion reduces mitochondrial respiration and content decreasing endurance [78][79][84]. In particular, p53 controls mitochondrial respiration by disrupting the equilibrium between glycolytic and oxidative pathways, by translocating to mitochondria and activating TFAM [85][86]. The mechanism appears to be reliant on the amount of training received [87]. In fact, healthy males who performed sprint interval training experienced a considerable increase in their muscle fibers’ maximal mitochondrial respiration, which was correlated with an increase in PGC-1α and p53 levels [87]. Overall, these findings imply that exercise activates different intracellular pathways that favor mitochondria biogenesis, depending on training intensity.
Physical activity and exercise have also been shown to control mitophagy and lysosome biogenesis in cardiac mitochondria [88]. Through promoting mitochondrial turnover, exercise enhances mitochondrial quality and function [88]. For example, acute exercise triggers autophagy in skeletal and cardiac muscle and exercise training induces the selective macroautophagy aimed to remove damaged mitochondria (mitophagy) [88]. As AMPK increases autophagy and given that exercise can induce AMPK, exercise likely induces mitochondrial turnover by activating AMPK-dependent mechanisms [88].
One hallmark of mitochondrial dysfunction is altered mitochondrial morphology a process finely regulated by fusion and fission processes [89]. Exercise affects mitochondrial morphology by activating specific molecular mechanisms. For example, the muscle-specific gene Zmynd17 (MSS51 mitochondrial translational activator) is known to control mitochondrial quality in muscle, especially in fast glycolytic muscles [90][91]. It has also been shown that acute exercise increases mitofusins’ expression in skeletal muscle and stimulates mitochondrial fusion by activating the PGC-1α/ERRα pathway [86]. PGC-1α overexpression in muscle leads to dense mitochondria, increasing endurance [92]. It has been reported that different exercise protocols induce mitochondrial fusion and increased mitofusin 2 (MFN2) [93]. Similarly, following exercise in healthy and moderately active subjects, dynamin-related protein 1 (DRP1) and MFN2 gene expression levels rapidly increased [94][95][96]. In this line, several studies show that acute exercise reduces mitochondrial fission in a β-adrenergic-dependent manner, mainly owing to DRP1 inactivation [92]. Exercise controls fission and fusion processes in skeletal muscle, also affecting Ca2+ handling. Indeed, ryanodine receptor 1 fragmentation and the subsequent increase in Ca2+ release in the cytosol are acutely induced by high-intensity interval training [97]. Altogether, these findings suggest that exercise turns on particular intracellular pathways to correct abnormalities in mitochondrial dynamics, indicating exercise-induced intracellular plasticity.
The PA can also modulate mitochondrial function by altering the mitochondrial respiratory chain plasticity. Electrons produced in diverse metabolic reactions are channeled into the mitochondrial electron transporting chain (ETC) to power the oxidative phosphorylation process. Structurally, ETC encompasses complex I to IV of OXPHOS. ETC plasticity involves plastic changes from freely moving complexes to super-assembled structures, called supercomplexes (SCs), and vice versa [98]. Although the physiology of respiratory SCs formation is not fully understood, there is evidence that they act by minimizing the leakage of electrons, due to an increase in the channeling of the flow of electrons, making mitochondria more efficient and reducing ROS formation [98]. In fact, mitochondrial SCs plasticity has been shown to be influenced by changes in energy demand [99]. A study of physical training in sedentary older subjects showed that exercise affected the stoichiometry of SCs formation in old age [100]. Such evidence reinforces a possible role of PA and exercise in mitochondrial plasticity modulation across different tissues.
Oxidative stress has been implicated in PD [101]. As mentioned, mitochondrial SCs formation can attenuate mitochondrial ROS production. However, mitochondrial ROS production is a natural byproduct of ETC activity, accounting for approximately 90% of cellular ROS. This chronic mitochondrial ROS generation can underlie the oxidative damage in many pathologies. In particular, ROS production during exercise can have an impact on the oxidative status of the cell. Remarkably, although regular PA stimulates health improvements, severe and/or long exercise produces ROS exacerbation, as demonstrated by increased oxidative damage biomarkers in skeletal muscles and blood [102]. Depending on the mode, intensity, and duration of exercise, the amount of ROS could determine the type of response from oxidative damage to adaptive signaling responses [102].
Although all of these beneficial effects of PA and exercise on enhancing mitochondrial biogenesis and function were known in healthy subjects, it is not clear if these effects can also be obtained in individuals with PD. It is relevant to investigate the effects of different exercise protocols and durations on motor coordination, cognitive aspects, and other (non-)motor symptoms, having mitochondrial performance as a surrogate pattern for the same cohort, and thus be able to verify how an exercise-boosted mitochondrial remodeling impacts the quality of life of patients with PD. By determining mitochondrial biogenesis signaling (PGC-1α, Nrf1, and TFAM), mitochondrial structure (oxidative phosphorylation system protein levels and SCs), mitochondrial network morphology, and mitochondrial respiratory capacity in PD patients, it would be possible to correlate with signs of improvements in motor behavior and quality of life. These studies may enable the characterization of the neuroprotective and motor effects of exercise mediated by mitochondrial modulation specifics of PD patients.

References

  1. Heemels, M.T. Neurodegenerative diseases. Nature 2016, 539, 179.
  2. Tysnes, O.B.; Storstein, A. Epidemiology of Parkinson’s disease. J. Neural. Transm. (Vienna) 2017, 124, 901–905.
  3. Brakedal, B.; Toker, L.; Haugarvoll, K.; Tzoulis, C. A nationwide study of the incidence, prevalence and mortality of Parkinson’s disease in the Norwegian population. NPJ Park. Dis. 2022, 8, 19.
  4. Dorsey, E.R.; Bloem, B.R. The Parkinson Pandemic—A Call to Action. JAMA Neurol. 2018, 75, 9–10.
  5. Dorsey, E.R.; Sherer, T.; Okun, M.S.; Bloem, B.R. The Emerging Evidence of the Parkinson Pandemic. J. Park. Dis. 2018, 8, S3–S8.
  6. Ou, Z.; Pan, J.; Tang, S.; Duan, D.; Yu, D.; Nong, H.; Wang, Z. Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson’s Disease in 204 Countries/Territories From 1990 to 2019. Front. Public Health 2021, 9, 776847.
  7. Bandres-Ciga, S.; Diez-Fairen, M.; Kim, J.J.; Singleton, A.B. Genetics of Parkinson’s disease: An introspection of its journey towards precision medicine. Neurobiol. Dis. 2020, 137, 104782.
  8. Klein, C.; Westenberger, A. Genetics of Parkinson’s disease. Cold Spring Harb. Perspect. Med. 2012, 2, a008888.
  9. Corti, O.; Lesage, S.; Brice, A. What Genetics Tells Us about the Causes and Mechanisms of Parkinson’s Disease. Physiol. Rev. 2011, 91, 1161–1218.
  10. Speelman, A.D.; van de Warrenburg, B.P.; van Nimwegen, M.; Petzinger, G.M.; Munneke, M.; Bloem, B.R. How might physical activity benefit patients with Parkinson disease? Nat. Rev. Neurol. 2011, 7, 528–534.
  11. Yang, Y.; Chen, L.; Yao, J.; Wang, N.; Liu, D.; Wang, Y.; Liu, D.; Wu, W.; Jiang, T.; Wang, Z. Early implementation of intended exercise improves quality of life in Parkinson’s disease patients. Neurol. Sci. 2022, 43, 1761–1767.
  12. Liguori, G. ACSM’s Guidelines for Exercise Testing and Prescription, 11th ed.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2021.
  13. Schenkman, M.; Cutson, T.M.; Kuchibhatla, M.; Chandler, J.; Pieper, C.F.; Ray, L.; Laub, K.C. Exercise to improve spinal flexibility and function for people with Parkinson’s disease: A randomized, controlled trial. J. Am. Geriatr. Soc. 1998, 46, 1207–1216.
  14. Gaßner, H.; Steib, S.; Klamroth, S.; Pasluosta, C.F.; Adler, W.; Eskofier, B.M.; Pfeifer, K.; Winkler, J.; Klucken, J. Perturbation Treadmill Training Improves Clinical Characteristics of Gait and Balance in Parkinson’s Disease. J. Park. Dis. 2019, 9, 413–426.
  15. Mehrholz, J.; Friis, R.; Kugler, J.; Twork, S.; Storch, A.; Pohl, M. Treadmill training for patients with Parkinson Disease. An abridged version of a Cochrane Review. Eur. J. Phys. Rehabil. Med. 2016, 52, 704–713.
  16. Mehrholz, J.; Kugler, J.; Storch, A.; Pohl, M.; Hirsch, K.; Elsner, B. Treadmill training for patients with Parkinson’s disease. Cochrane Database Syst. Rev. 2015, 2015, CD007830.
  17. Herman, T.; Giladi, N.; Hausdorff, J.M. Treadmill training for the treatment of gait disturbances in people with Parkinson’s disease: A mini-review. J. Neural Transm. 2009, 116, 307–318.
  18. Berra, E.; De Icco, R.; Avenali, M.; Dagna, C.; Cristina, S.; Pacchetti, C.; Fresia, M.; Sandrini, G.; Tassorelli, C. Body Weight Support Combined With Treadmill in the Rehabilitation of Parkinsonian Gait: A Review of Literature and New Data From a Controlled Study. Front. Neurol. 2018, 9, 1066.
  19. Ganesan, M.; Sathyaprabha, T.N.; Gupta, A.; Pal, P.K. Effect of Partial Weight-Supported Treadmill Gait Training on Balance in Patients With Parkinson Disease. PM&R 2014, 6, 22–33.
  20. Toole, T.; Maitland, C.G.; Warren, E.; Hubmann, M.F.; Panton, L. The effects of loading and unloading treadmill walking on balance, gait, fall risk, and daily function in Parkinsonism. NeuroRehabilitation 2005, 20, 307–322.
  21. Ustinova, K.; Chernikova, L.; Bilimenko, A.; Telenkov, A.; Epstein, N. Effect of robotic locomotor training in an individual with Parkinson’s disease: A case report. Disabil. Rehabil. Assist. Technol. 2011, 6, 77–85.
  22. Kang, M.-G.; Yun, S.J.; Shin, H.I.; Kim, E.; Lee, H.H.; Oh, B.-M.; Gil Seo, H. Effects of robot-assisted gait training in patients with Parkinson’s disease: Study protocol for a randomized controlled trial. Trials 2019, 20, 15.
  23. Van Diest, M.; Lamoth, C.J.C.; Stegenga, J.; Verkerke, G.J.; Postema, K. Exergaming for balance training of elderly: State of the art and future developments. J. Neuroeng. Rehabil. 2013, 10, 101.
  24. Mirelman, A.; Maidan, I.; Deutsch, J.E. Virtual reality and motor imagery: Promising tools for assessment and therapy in Parkinson’s disease. Mov. Disord. 2013, 28, 1597–1608.
  25. Feng, H.; Li, C.; Liu, J.; Wang, L.; Ma, J.; Li, G.; Gan, L.; Shang, X.; Wu, Z. Virtual Reality Rehabilitation Versus Conventional Physical Therapy for Improving Balance and Gait in Parkinson’s Disease Patients: A Randomized Controlled Trial. J. Pharmacol. Exp. Ther. 2019, 25, 4186–4192.
  26. Nadeau, A.; Lungu, O.; Duchesne, C.; Robillard, M.; Bore, A.; Bobeuf, F.; Plamondon, R.; Lafontaine, A.-L.; Gheysen, F.; Bherer, L.; et al. A 12-Week Cycling Training Regimen Improves Gait and Executive Functions Concomitantly in People with Parkinson’s Disease. Front. Hum. Neurosci. 2016, 10, 690.
  27. Rosenfeldt, A.B.; Dey, T.; Alberts, J.L. Aerobic Exercise Preserves Olfaction Function in Individuals with Parkinson’s Disease. Park. Dis. 2016, 2016, 1–6.
  28. Snijders, A.H.; Toni, I.; Ružička, E.; Bloem, B.R. Bicycling breaks the ice for freezers of gait. Mov. Disord. 2011, 26, 367–371.
  29. Fiorelli, C.M.; Ciolac, E.G.; Simieli, L.; Silva, F.A.; Fernandes, B.; Christofoletti, G.; Barbieri, F.A. Differential Acute Effect of High-Intensity Interval or Continuous Moderate Exercise on Cognition in Individuals With Parkinson’s Disease. J. Phys. Act. Health 2019, 16, 157–164.
  30. Uygur, M.; Bellumori, M.; Knight, C.A. Effects of a low-resistance, interval bicycling intervention in Parkinson’s Disease. Physiother. Theory Pract. 2017, 33, 897–904.
  31. Duchesne, C.; Lungu, O.; Nadeau, A.; Robillard, M.; Boré, A.; Bobeuf, F.; Lafontaine, A.; Gheysen, F.; Bherer, L.; Doyon, J. Enhancing both motor and cognitive functioning in Parkinson’s disease: Aerobic exercise as a rehabilitative intervention. Brain Cogn. 2015, 99, 68–77.
  32. Duchesne, C.; Gheysen, F.; Bore, A.; Albouy, G.; Nadeau, A.; Robillard, M.; Bobeuf, F.; Lafontaine, A.; Lungu, O.; Bherer, L.; et al. Influence of aerobic exercise training on the neural correlates of motor learning in Parkinson’s disease individuals. NeuroImage Clin. 2016, 12, 559–569.
  33. Steib, S.; Wanner, P.; Adler, W.; Winkler, J.; Klucken, J.; Pfeifer, K. A Single Bout of Aerobic Exercise Improves Motor Skill Consolidation in Parkinson’s Disease. Front. Aging Neurosci. 2018, 10, 328.
  34. Allen, N.E.; Sherrington, C.; Paul, S.S.; Canning, C.G. Balance and falls in Parkinson’s disease: A meta-analysis of the effect of exercise and motor training. Mov. Disord. 2011, 26, 1605–1615.
  35. Shen, X.; Wong-Yu, I.S.; Mak, M.K. Effects of Exercise on Falls, Balance, and Gait Ability in Parkinson’s Disease: A Meta-analysis. Neurorehabil. Neural Repair 2016, 30, 512–527.
  36. Pompeu, J.E.; Arduini, L.A.; Botelho, A.R.; Fonseca, M.B.; Pompeu, S.M.; Torriani-Pasin, C.; Deutsch, J.E. Feasibility, safety and outcomes of playing Kinect Adventures! for people with Parkinson’s disease: A pilot study. Physiotherapy 2014, 100, 162–168.
  37. Barry, G.; Galna, B.; Rochester, L. The role of exergaming in Parkinson’s disease rehabilitation: A systematic review of the evidence. J. Neuroeng. Rehabil. 2014, 11, 33.
  38. Dibble, L.E.; Hale, T.F.; Marcus, R.; Gerber, J.P.; LaStayo, P.C. High intensity eccentric resistance training decreases bradykinesia and improves quality of life in persons with Parkinson’s disease: A preliminary study. Park. Relat. Disord. 2009, 15, 752–757.
  39. Saltychev, M.; Bärlund, E.; Paltamaa, J.; Katajapuu, N.; Laimi, K. Progressive resistance training in Parkinson’s disease: A systematic review and meta-analysis. BMJ Open 2016, 6, e008756.
  40. Zhang, T.; Liu, W.; Gao, S. Effects of mind-body exercises on cognitive impairment in people with Parkinson’s disease: A mini-review. Front. Neurol. 2022, 13.
  41. Duncan, R.P.; Earhart, G.M. Randomized Controlled Trial of Community-Based Dancing to Modify Disease Progression in Parkinson Disease. Neurorehabilit. Neural Repair 2012, 26, 132–143.
  42. Schenkman, M.; Moore, C.G.; Kohrt, W.M.; Hall, D.A.; Delitto, A.; Comella, C.L.; Josbeno, D.A.; Christiansen, C.L.; Berman, B.D.; Kluger, B.M.; et al. Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial. JAMA Neurol. 2018, 75, 219–226.
  43. Cariati, I.; Masuelli, L.; Bei, R.; Tancredi, V.; Frank, C.; D’Arcangelo, G. Neurodegeneration in Niemann–Pick Type C Disease: An Updated Review on Pharmacological and Non-Pharmacological Approaches to Counteract Brain and Cognitive Impairment. Int. J. Mol. Sci. 2021, 22, 6600.
  44. Bloomer, R.J.; Schilling, B.K.; Karlage, R.E.; Ledoux, M.S.; Pfeiffer, R.F.; Callegari, J. Effect of Resistance Training on Blood Oxidative Stress in Parkinson Disease. Med. Sci. Sports Exerc. 2008, 40, 1385–1389.
  45. van der Kolk, N.M.; de Vries, N.M.; Kessels, R.P.C.; Joosten, H.; Zwinderman, A.H.; Post, B.; Bloem, B.R. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson’s disease: A double-blind, randomised controlled trial. Lancet Neurol. 2019, 18, 998–1008.
  46. Batouli, S.A.H.; Saba, V. At least eighty percent of brain grey matter is modifiable by physical activity: A review study. Behav. Brain Res. 2017, 332, 204–217.
  47. Pereira, A.C.; Huddleston, D.E.; Brickman, A.M.; Sosunov, A.A.; Hen, R.; McKhann, G.M.; Sloan, R.; Gage, F.H.; Brown, T.R.; Small, S.A. An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proc. Natl. Acad. Sci. USA 2007, 104, 5638–5643.
  48. Prusiner, S.B. A Unifying Role for Prions in Neurodegenerative Diseases. Science 2012, 336, 1511–1513.
  49. Braak, H.; Del Tredici, K.; Rüb, U.; de Vos, R.A.; Steur, E.N.J.; Braak, E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging 2003, 24, 197–211.
  50. Del Tredici, K.; Braak, H. Review: Sporadic Parkinson’s disease: Development and distribution ofα-synuclein pathology. Neuropathol. Appl. Neurobiol. 2016, 42, 33–50.
  51. Villar-Conde, S.; Astillero-Lopez, V.; Gonzalez-Rodriguez, M.; Villanueva-Anguita, P.; Saiz-Sanchez, D.; Martinez-Marcos, A.; Flores-Cuadrado, A.; Ubeda-Bañon, I. The Human Hippocampus in Parkinson’s Disease: An Integrative Stereological and Proteomic Study. J. Park. Dis. 2021, 11, 1345–1365.
  52. Yanagisawa, N. Functions and dysfunctions of the basal ganglia in humans. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2018, 94, 275–304.
  53. Heinzel, S.; Berg, D.; Gasser, T.; Chen, H.; Yao, C.; Postuma, R.B.; the MDS Task Force on the Definition of Parkinson’s Disease. Update of the MDS research criteria for prodromal Parkinson’s disease. Mov. Disord. 2019, 34, 1464–1470.
  54. Tandon, S.D.; Colon, L.; Vega, P.; Murphy, J.; Alonso, A. Birth outcomes associated with receipt of group prenatal care among low-income Hispanic women. J. Midwifery Women’s Health 2012, 57, 476–481.
  55. Gelpi, E.; Navarro-Otano, J.; Tolosa, E.; Gaig, C.; Compta, Y.; Rey, M.J.; Martí, M.J.; Hernández, I.; Valldeoriola, F.; Reñé, R.; et al. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov. Disord. 2014, 29, 1010–1018.
  56. Lim, S.-Y.; Fox, S.H.; Lang, A.E. Overview of the Extranigral Aspects of Parkinson Disease. Arch. Neurol. 2009, 66, 167–172.
  57. Aguer, C.; Loro, E.; Di Raimondo, D. Editorial: The Role of the Muscle Secretome in Health and Disease. Front. Physiol. 2020, 11, 1101.
  58. Leuchtmann, A.B.; Adak, V.; Dilbaz, S.; Handschin, C. The Role of the Skeletal Muscle Secretome in Mediating Endurance and Resistance Training Adaptations. Front. Physiol. 2021, 12, 1296.
  59. Swain, R.A.; Berggren, K.L.; Kerr, A.L.; Patel, A.; Peplinski, C.; Sikorski, A.M. On Aerobic Exercise and Behavioral and Neural Plasticity. Brain Sci. 2012, 2, 709–744.
  60. Hawley, J.A.; Hargreaves, M.; Joyner, M.J.; Zierath, J.R. Integrative Biology of Exercise. Cell 2014, 159, 738–749.
  61. Bassel-Duby, R.; Olson, E.N. Signaling Pathways in Skeletal Muscle Remodeling. Annu. Rev. Biochem. 2006, 75, 19–37.
  62. Bonanni, R.; Cariati, I.; Tarantino, U.; D’Arcangelo, G.; Tancredi, V. Physical Exercise and Health: A Focus on Its Protective Role in Neurodegenerative Diseases. J. Funct. Morphol. Kinesiol. 2022, 7, 38.
  63. Pedersen, B.K.; Pedersen, M.; Krabbe, K.S.; Bruunsgaard, H.; Matthews, V.B.; Febbraio, M.A. Role of exercise-induced brain-derived neurotrophic factor production in the regulation of energy homeostasis in mammals. Exp. Physiol. 2009, 94, 1153–1160.
  64. Pinho, R.A.; Aguiar, A.S., Jr.; Radak, Z. Effects of Resistance Exercise on Cerebral Redox Regulation and Cognition: An Interplay Between Muscle and Brain. Antioxidants 2019, 8, 529.
  65. Kang, T.-C. Nuclear Factor-Erythroid 2-Related Factor 2 (Nrf2) and Mitochondrial Dynamics/Mitophagy in Neurological Diseases. Antioxidants 2020, 9, 617.
  66. Moon, H.Y.; Becke, A.; Berron, D.; Becker, B.; Sah, N.; Benoni, G.; Janke, E.; Lubejko, S.; Greig, N.H.; Mattison, J.A.; et al. Running-Induced Systemic Cathepsin B Secretion Is Associated with Memory Function. Cell Metab. 2016, 24, 332–340.
  67. Kupr, B.; Handschin, C. Complex Coordination of Cell Plasticity by a PGC-1α-controlled Transcriptional Network in Skeletal Muscle. Front. Physiol. 2015, 6, 325.
  68. Schnyder, S.; Handschin, C. Skeletal muscle as an endocrine organ: PGC-1alpha, myokines and exercise. Bone 2015, 80, 115–125.
  69. Delezie, J.; Handschin, C. Endocrine Crosstalk Between Skeletal Muscle and the Brain. Front. Neurol. 2018, 9, 698.
  70. Wrann, C.D.; White, J.P.; Salogiannnis, J.; Laznik-Bogoslavski, D.; Wu, J.; Ma, D.; Lin, J.D.; Greenberg, M.E.; Spiegelman, B.M. Exercise induces hippocampal BDNF through a PGC-1alpha/FNDC5 pathway. Cell Metab. 2013, 18, 649–659.
  71. Pedersen, B.K. Physical activity and muscle–brain crosstalk. Nat. Rev. Endocrinol. 2019, 15, 383–392.
  72. Grilo, L.F.; Diniz, M.S.; Tocantins, C.; Areia, A.L.; Pereira, S.P. The Endocrine–Metabolic Axis Regulation in Offspring Exposed to Maternal Obesity—Cause or Consequence in Metabolic Disease Programming? Obesities 2022, 2, 236–255.
  73. Colucci-D’Amato, L.; Speranza, L.; Volpicelli, F. Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer. Int. J. Mol. Sci. 2020, 21, 7777.
  74. Ambrosi, G.; Ghezzi, C.; Sepe, S.; Milanese, C.; Payan-Gomez, C.; Bombardieri, C.R.; Armentero, M.-T.; Zangaglia, R.; Pacchetti, C.; Mastroberardino, P.G.; et al. Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson’s disease. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 2014, 1842, 1385–1394.
  75. Teves, J.M.Y.; Bhargava, V.; Kirwan, K.R.; Corenblum, M.J.; Justiniano, R.; Wondrak, G.T.; Anandhan, A.; Flores, A.J.; Schipper, D.A.; Khalpey, Z.; et al. Parkinson’s Disease Skin Fibroblasts Display Signature Alterations in Growth, Redox Homeostasis, Mitochondrial Function, and Autophagy. Front. Neurosci. 2017, 11, 737.
  76. Deus, C.M.; Pereira, S.P.; Cunha-Oliveira, T.; Teixeira, J.; Simões, R.F.; Cagide, F.; Benfeito, S.; Borges, F.; Raimundo, N.; Oliveira, P.J. A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson’s disease patients. Redox Biol. 2021, 45, 102037.
  77. Milanese, C.; Payán-Gómez, C.; Galvani, M.; González, N.M.; Tresini, M.; Abdellah, S.N.; Van Roon-Mom, W.M.C.; Figini, S.; Marinus, J.; Van Hilten, J.J.; et al. Peripheral mitochondrial function correlates with clinical severity in idiopathic Parkinson’s disease. Mov. Disord. 2019, 34, 1192–1202.
  78. Ferreira, R.; Vitorino, R.; Padrão, A.I.; Espadas, G.; Mancuso, F.M.; Moreira-Gonçalves, D.; Castro-Sousa, G.; Henriques-Coelho, T.; Oliveira, P.A.; Barros, A.S.; et al. Lifelong Exercise Training Modulates Cardiac Mitochondrial Phosphoproteome in Rats. J. Proteome Res. 2014, 13, 2045–2055.
  79. Carter, H.N.; Chen, C.C.W.; Hood, D.A. Mitochondria, Muscle Health, and Exercise with Advancing Age. Physiology 2015, 30, 208–223.
  80. Islam, H.; Hood, D.A.; Gurd, B.J. Looking beyond PGC-1α: Emerging regulators of exercise-induced skeletal muscle mitochondrial biogenesis and their activation by dietary compounds. Appl. Physiol. Nutr. Metab. 2020, 45, 11–23.
  81. Memme, J.M.; Erlich, A.T.; Phukan, G.; Hood, D.A. Exercise and mitochondrial health. J. Physiol. 2021, 599, 803–817.
  82. Belardinelli, R.; Georgiou, D.; Cianci, G.; Purcaro, A. 10-year exercise training in chronic heart failure: A randomized controlled trial. J. Am. Coll. Cardiol. 2012, 60, 1521–1528.
  83. Kachur, S.; Lavie, C.J.; Morera, R.; Ozemek, C.; Milani, R.V. Exercise training and cardiac rehabilitation in cardiovascular disease. Expert Rev. Cardiovasc. Ther. 2019, 17, 585–596.
  84. Roh, J.; Rhee, J.; Chaudhari, V.; Rosenzweig, A. The Role of Exercise in Cardiac Aging: From Physiology to Molecular Mechanisms. Circ. Res. 2016, 118, 279–295.
  85. Lopez-Otin, C.; Blasco, M.A.; Partridge, L.; Serrano, M.; Kroemer, G. The hallmarks of aging. Cell 2013, 153, 1194–1217.
  86. Cartoni, R.; Leger, B.; Hock, M.B.; Praz, M.; Crettenand, A.; Pich, S.; Ziltener, J.L.; Luthi, F.; Deriaz, O.; Zorzano, A.; et al. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J. Physiol. 2005, 567 Pt 1, 349–358.
  87. Kim, Y.; Triolo, M.; Hood, D.A. Impact of Aging and Exercise on Mitochondrial Quality Control in Skeletal Muscle. Oxidative Med. Cell. Longev. 2017, 2017, 1–16.
  88. Sorriento, D.; Di Vaia, E.; Iaccarino, G. Physical Exercise: A Novel Tool to Protect Mitochondrial Health. Front. Physiol. 2021, 12, 660068.
  89. Ding, W.X.; Yin, X.M. Mitophagy: Mechanisms, pathophysiological roles, and analysis. Biol. Chem. 2012, 393, 547–564.
  90. Yoshioka, K.; Fujita, R.; Seko, D.; Suematsu, T.; Miura, S.; Ono, Y. Distinct Roles of Zmynd17 and PGC1α in Mitochondrial Quality Control and Biogenesis in Skeletal Muscle. Front. Cell Dev. Biol. 2019, 7, 330.
  91. Fujita, R.; Yoshioka, K.; Seko, D.; Suematsu, T.; Mitsuhashi, S.; Senoo, N.; Miura, S.; Nishino, I.; Ono, Y. Zmynd17 controls muscle mitochondrial quality and whole-body metabolism. FASEB J. 2018, 32, 5012–5025.
  92. Casuso, R.A.; Huertas, J.R. The emerging role of skeletal muscle mitochondrial dynamics in exercise and ageing. Ageing Res. Rev. 2020, 58, 101025.
  93. Huertas, J.R.; Ruiz-Ojeda, F.J.; Plaza-Díaz, J.; Nordsborg, N.B.; Martín-Albo, J.; Rueda-Robles, A.; Casuso, R.A. Human muscular mitochondrial fusion in athletes during exercise. FASEB J. 2019, 33, 12087–12098.
  94. Fiorenza, M.; Gunnarsson, T.P.; Hostrup, M.; Iaia, F.M.; Schena, F.; Pilegaard, H.; Bangsbo, J. Metabolic stress-dependent regulation of the mitochondrial biogenic molecular response to high-intensity exercise in human skeletal muscle. J. Physiol. 2018, 596, 2823–2840.
  95. Cribbs, J.T.; Strack, S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep. 2007, 8, 939–944.
  96. Granata, C.; Oliveira, R.S.F.; Little, J.P.; Renner, K.; Bishop, D.J. Sprint-interval but not continuous exercise increases PGC-1α protein content and p53 phosphorylation in nuclear fractions of human skeletal muscle. Sci. Rep. 2017, 7, srep44227.
  97. Place, N.; Ivarsson, N.; Venckunas, T.; Neyroud, D.; Brazaitis, M.; Cheng, A.J.; Ochala, J.; Kamandulis, S.; Girard, S.; Volungevičius, G.; et al. Ryanodine receptor fragmentation and sarcoplasmic reticulum Ca 2+ leak after one session of high-intensity interval exercise. Proc. Natl. Acad. Sci. USA 2015, 112, 15492–15497.
  98. Acin-Perez, R.; Enriquez, J.A. The function of the respiratory supercomplexes: The plasticity model. Biochim. Biophys. Acta (BBA)-Bioenerg. 2014, 1837, 444–450.
  99. Roberts, F.L.; Markby, G.R. New Insights into Molecular Mechanisms Mediating Adaptation to Exercise; A Review Focusing on Mitochondrial Biogenesis, Mitochondrial Function, Mitophagy and Autophagy. Cells 2021, 10, 2639.
  100. Greggio, C.; Jha, P.; Kulkarni, S.S.; Lagarrigue, S.; Broskey, N.T.; Boutant, M.; Wang, X.; Alonso, S.C.; Ofori, E.; Auwerx, J.; et al. Enhanced Respiratory Chain Supercomplex Formation in Response to Exercise in Human Skeletal Muscle. Cell Metab. 2017, 25, 301–311.
  101. Deus, C.M.; Teixeira, J.; Raimundo, N.; Tucci, P.; Borges, F.; Saso, L.; Oliveira, P.J. Modulation of cellular redox environment as a novel therapeutic strategy for Parkinson’s disease. Eur. J. Clin. Investig. 2022, 52.
  102. Powers, S.K.; Deminice, R.; Ozdemir, M.; Yoshihara, T.; Bomkamp, M.P.; Hyatt, H. Exercise-induced oxidative stress: Friend or foe? J. Sport Health Sci. 2020, 9, 415–425.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Cell Biology
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Juan Carlos Magaña
,
Cláudia M. Deus
,
Maria Giné-Garriga
,
Joel Montané
,
Susana P. Pereira
View Times: 419
Entry Collection: Neurodegeneration
Revisions: 2 times (View History)
Update Date: 23 Dec 2022
Table of Contents
    1000/1000
    Hot Most Recent
    Video Production Service
    Feedback